Overview

Adjuvant CCRT vs CT in Minimal N2 NSCLC

Status:
Completed
Trial end date:
2021-01-18
Target enrollment:
Participant gender:
Summary
This study propose adjuvant concurrent chemoradiotherapy vs chemotherapy alone in completely resected microscopic N2 NSCLC
Phase:
Phase 2
Details
Lead Sponsor:
Samsung Medical Center
Treatments:
Paclitaxel